Unusual presentation of tuberculosis in an infliximab-treated patient - Which is the correct TB screening before starting a biologic?

Dermatologic Therapy

Volumn 23, Issue SUPPL. 1, 2010, Pages

  Gori, Alessia ^a   Fabroni, Caterina ^a   Prignano, Francesca ^a   Lotti, Torello ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Psoriasis; Quantiferon assay; TB screening; Tuberculin skin test; Tuberculosis (TB); Tumor necrosis factor alpha (TNF )

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; CEFTRIAXONE; ETHAMBUTOL; INFLIXIMAB; ISONIAZID; PSORALEN; PYRAZINAMIDE; RETINOID; RIFAMPICIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BIOLOGICAL THERAPY; CASE REPORT; DISEASE SEVERITY; FEVER; HEADACHE; HUMAN; INTESTINE TUBERCULOSIS; LUNG TUBERCULOSIS; MALE; PSORIASIS; SCREENING TEST; SIDE EFFECT; SWEAT; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOUS LYMPHADENITIS; ULTRAVIOLET A RADIATION;

ADULT; ANTIBODIES, MONOCLONAL; DERMATOLOGIC AGENTS; ETHAMBUTOL; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; INTESTINAL DISEASES; ISONIAZID; LATENT TUBERCULOSIS; MALE; MASS SCREENING; MYCOBACTERIUM TUBERCULOSIS; PSORIASIS; RIFAMPIN; TUBERCULOSIS, GASTROINTESTINAL; TUBERCULOSIS, LYMPH NODE; TUBERCULOSIS, PULMONARY;

EID: 74949086690     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/j.1529-8019.2009.01278.x     Document Type: Article

References (7)

1. Ehlers S. Tumor necrosis factor and its blockade in granulomatous infections: differential modes of action of infliximab and etanercept? Clin Infect Dis 2005 : 41 : S199 S203.
2. Arend SM, Breedveld FC, Van Dissel JT. TNF-α blockade and tuberculosis: better look before you leap. Neth J Med 2003 : 61 : 111 119.
3. Gardam MA, Keystone EC, Menzies R, et al. Anti-tumor necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. Lancet Infect Dis 2003 : 3 : 148 155.
4. Pai M, Riley LW, Colford JM. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 2004 : 4 : 761 776.
5. Mazurek GH, Villarino ME Centers for Disease Control and Prevention. Guidelines for using QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. Centers for Disease Control and Prevention.
6. Tat D, Polenakovik H, Herchilne T. Comparing interferon-γ release assay with tuberculin skin test readings at 48-72 hours and 144-168 hours with use of 2 commercial reagents. Clin Infect Dis 2005 : 40 (2 246 250.
7. Mazurek GH, LoBue PA, Daley CL, et al. Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. JAMA 2001 : 286 (14 1740 1747.